Ignite Creation Date:
2024-05-06 @ 9:30 AM
Last Modification Date:
2024-10-26 @ 12:15 PM
Study NCT ID:
NCT02999906
Status:
WITHDRAWN
Last Update Posted:
2017-11-01
First Post:
2016-12-19
Brief Title:
Study to Compare Triple Therapy Oral Treprostinil Ambrisentan and Tadalafil With Dual Therapy Ambrisentan Tadalafil and Placebo in Subjects With Pulmonary Arterial Hypertension
Sponsor:
United Therapeutics
Organization:
United Therapeutics
Organization Data
Organization:
United Therapeutics
Class:
INDUSTRY
Study ID:
TDE-PH-313
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
United Therapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None